Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger.

Niger cost analysis first 1000 days lipid-based nutritional supplements—small quantity (SQ-LNS) maternal and child nutrition

Journal

Food and nutrition bulletin
ISSN: 1564-8265
Titre abrégé: Food Nutr Bull
Pays: United States
ID NLM: 7906418

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 2 9 2021
medline: 27 1 2022
entrez: 1 9 2021
Statut: ppublish

Résumé

In January 2015, the Alliance for International Medical Action and Bien Être de la Femme et de l'Enfant au Niger launched the 1000 Days Program in Mirriah District, Niger, to provide an integrated package of maternal and pediatric preventive and curative interventions. A new component of the package was the provision of small-quantity lipid-based nutritional supplements (SQ-LNS) for children 6 to 23 months. The objective of this study was to estimate the costs associated with providing the 1000 days package. Activity-based costing was used to estimate the total costs of the 10 activities included in the 1000 days package and also the incremental costs of new interventions, those beyond the standard of care. The total cost of the 1000 Days Program was US$2.31 million for 9000 mother-child pairs. The average cost per pair was US$257 or US$103 per year. Incremental costs for new interventions accounted for 56% of program costs. Small-quantity lipid-based nutritional supplement represented 30% of incremental costs. A combination of efficiency measures could lower program costs by 15%. This study is the first to estimate the costs of an integrated, preventative-curative package of maternal-child health interventions with SQ-LNS. Implementing the 1000 days package across Niger will be challenging with only the country's domestic health resources. Efficiency measures and creative financing arrangements, including support from external partners, should be explored. The approach and results described can inform future resource mobilization, financing, and budgeting efforts to scale the 1000 days or similar programs.

Sections du résumé

BACKGROUND
In January 2015, the Alliance for International Medical Action and Bien Être de la Femme et de l'Enfant au Niger launched the 1000 Days Program in Mirriah District, Niger, to provide an integrated package of maternal and pediatric preventive and curative interventions. A new component of the package was the provision of small-quantity lipid-based nutritional supplements (SQ-LNS) for children 6 to 23 months.
OBJECTIVE
The objective of this study was to estimate the costs associated with providing the 1000 days package.
METHODS
Activity-based costing was used to estimate the total costs of the 10 activities included in the 1000 days package and also the incremental costs of new interventions, those beyond the standard of care.
RESULTS
The total cost of the 1000 Days Program was US$2.31 million for 9000 mother-child pairs. The average cost per pair was US$257 or US$103 per year. Incremental costs for new interventions accounted for 56% of program costs. Small-quantity lipid-based nutritional supplement represented 30% of incremental costs. A combination of efficiency measures could lower program costs by 15%.
CONCLUSIONS
This study is the first to estimate the costs of an integrated, preventative-curative package of maternal-child health interventions with SQ-LNS. Implementing the 1000 days package across Niger will be challenging with only the country's domestic health resources. Efficiency measures and creative financing arrangements, including support from external partners, should be explored. The approach and results described can inform future resource mobilization, financing, and budgeting efforts to scale the 1000 days or similar programs.

Identifiants

pubmed: 34467822
doi: 10.1177/03795721211039869
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

567-583

Auteurs

Lindsey Hiebert (L)

50296Yale University, New Haven, CT, USA.

Kevin Phelan (K)

The 560729Alliance for International Medical Action (ALIMA), Paris, France.

Moumouni Kinda (M)

The 560729Alliance for International Medical Action (ALIMA), Dakar, Senegal.

Nafissa Dan-Bouzoua (N)

The 560729Alliance for International Medical Action (ALIMA), Dakar, Senegal.

Maurice Kyungu (M)

The 560729Alliance for International Medical Action (ALIMA), Dakar, Senegal.

Thomas Bounameaux (T)

The 560729Alliance for International Medical Action (ALIMA), Dakar, Senegal.

Sani Sayadi (S)

531380Bien Être de la Femme et de l'Enfant (BEFEN), Niamey, Niger.

Oumarou Maidadji (O)

531380Bien Être de la Femme et de l'Enfant (BEFEN), Niamey, Niger.

Robert Hecht (R)

50296Yale University, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH